XORTX Therapeutics, Inc. (XRTX)
0.839
-0.05
(-5.73%)
USD |
NASDAQ |
Nov 20, 16:00
0.8101
-0.03
(-3.44%)
After-Hours: 20:00
XORTX Therapeutics Total Return Level : 0.839 for Nov. 20, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 20, 2026 | 0.839 |
| November 19, 2026 | 0.89 |
| November 18, 2026 | 1.06 |
| November 17, 2026 | 1.06 |
| November 16, 2026 | 1.04 |
| November 13, 2026 | 1.10 |
| November 12, 2026 | 0.92 |
| November 11, 2026 | 0.89 |
| November 10, 2026 | 0.85 |
| November 09, 2026 | 0.845 |
| November 06, 2026 | 0.91 |
| November 05, 2026 | 0.92 |
| November 04, 2026 | 0.99 |
| November 03, 2026 | 1.00 |
| November 02, 2026 | 1.01 |
| October 30, 2026 | 1.00 |
| October 29, 2026 | 1.03 |
| October 28, 2026 | 1.05 |
| October 27, 2026 | 1.10 |
| October 26, 2026 | 1.06 |
| October 23, 2026 | 0.9201 |
| October 22, 2026 | 0.9688 |
| October 21, 2026 | 0.9301 |
| October 20, 2026 | 0.9555 |
| October 19, 2026 | 1.01 |
| Date | Value |
|---|---|
| October 16, 2026 | 1.24 |
| October 15, 2026 | 1.42 |
| October 14, 2026 | 1.56 |
| October 13, 2026 | 1.68 |
| October 12, 2026 | 1.72 |
| October 09, 2026 | 1.41 |
| October 08, 2026 | 1.85 |
| October 07, 2026 | 1.745 |
| October 06, 2026 | 1.73 |
| October 05, 2026 | 1.70 |
| October 02, 2026 | 1.714 |
| October 01, 2026 | 1.73 |
| September 30, 2026 | 1.69 |
| September 29, 2026 | 1.70 |
| September 28, 2026 | 1.71 |
| September 25, 2026 | 1.69 |
| September 24, 2026 | 1.72 |
| September 23, 2026 | 1.70 |
| September 22, 2026 | 1.86 |
| September 21, 2026 | 1.95 |
| September 18, 2026 | 1.92 |
| September 17, 2026 | 1.66 |
| September 16, 2026 | 1.78 |
| September 15, 2026 | 1.88 |
| September 14, 2026 | 2.07 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Lexaria Bioscience Corp. | 4.03 |
| Target Group, Inc. (Canada) | 0.0011 |
| NervGen Pharma Corp. | 1.845 |
| Milestone Pharmaceuticals, Inc. | 0.3711 |
| Appili Therapeutics, Inc. | 0.001 |